MediWound Ltd
Research MediWound Ltd (MDWD) on Bullrun: market cap USD 193.71M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMDWD
- ExchangeNASDAQ
- CountryIsrael
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 193.71M
- Financial periodQ1 2026
- RevenueUSD 1.48M
- Net income-USD 2.95M
- Free cash flow-USD 8.57M
- Gross margin21.9%
Valuation Snapshot
latest market cap is USD 193.71M.
About MediWound Ltd
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.
Frequently asked questions
What is MediWound Ltd's market cap?
MediWound Ltd's market capitalization is USD 193.71M.
What does MediWound Ltd do?
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally.